- The GHEF was conceived in the wake of the Covid-19 pandemic
- The fund will focus on healthcare and the industries that are direct determinants of health, including energy transition and food agriculture
- Since its founding in 2013, OurCrowd has received over $1.9bn in commitments and deployed capital to more than 347 portfolio companies and 39 funds
Our Crowd has launched a $200 million global health equity fund in collaboration with the WHO Foundation. The news was announced at the Clinton Global Initiative.
The fund will focus on breakthrough technology solutions that can impact healthcare globally.
The GHEF was conceived in the wake of the Covid-19 pandemic, which exposed chronic weaknesses in health systems, the under-funding of healthcare and inequitable access to technology solutions.
In a statement, Jon Medved, founder and CEO of OurCrowd, explained why he formed the fund: “Covid-19 was a wake-up call for me as an investor. The pandemic opened my eyes to health inequity around the world and reinforced the potential of innovative technology to save lives.”
The Global Health Equity Fund will focus on healthcare and the industries that are direct determinants of health, including energy transition and food agriculture.
Also, The WHO Foundation and OurCrowd will create a global health advisory board to provide assistance to these companies so they can plan early for business models that combine economic return with equitable access.
The fund team will be led by Medved and OurCrowd managing partner Dr. Morris Laster, with the support of the WHO Foundation’s Chief Impact Investment Officer, Geetha Tharmaratnam.
Since its founding in 2013, OurCrowd has received more than $1.9 billion in commitments, and deployed capital into more than 347 portfolio companies and 39 funds across five continents. OurCrowd’s startups have recorded 59 exits to date.
Established in 2020 as an independent entity, the WHO Foundation complements and strengthens the work of the World Health Organization and its global network of partners by mobilizing new funding from diverse sources, including philanthropists, corporate entities and the general public.